Neoadjuvant fractionated versus hypofractionated chemoradiotherapy in resectable and borderline resectable pancreatic cancer

被引：0
|
作者：
Lee, Darren
Nelson, Bailey
Rai, Shesh
Rai, Jayesh
Wang, Kyle
Sohal, Davendra
Olowokure, Olugbenga Olanrele
Rojan, Adam
Patel, Sameer H.
Wilson, Gregory
Ahmad, Syed A.
Kharofa, Jordan
机构：
[1] Univ Cincinnati, Canc Ctr, Cincinnati, OH USA
[2] Kettering Lab Complex, Cincinnati, OH USA
[3] Univ Cincinnati, Div Hematol Oncol, Canc Ctr, Cincinnati, OH USA
[4] Univ Cincinnati, Cincinnati, OH USA
[5] Univ Cincinnati, Med Ctr, Cincinnati, OH 45267 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4161
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Neoadjuvant or Adjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer: Which Is Preferred?
    O'Reilly, Eileen M.
    Ferrone, Cristina
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (16) : 1757 - +
  • [32] Changes and prognostic impact of inflammatory nutritional factors during neoadjuvant chemoradiotherapy for patients with resectable and borderline resectable pancreatic cancer
    Oshima, Minoru
    Okano, Keiichi
    Suto, Hironobu
    Ando, Yasuhisa
    Kamada, Hideki
    Masaki, Tsutomu
    Takahashi, Shigeo
    Shibata, Toru
    Suzuki, Yasuyuki
    BMC GASTROENTEROLOGY, 2020, 20 (01)
  • [33] Changes and prognostic impact of inflammatory nutritional factors during neoadjuvant chemoradiotherapy for patients with resectable and borderline resectable pancreatic cancer
    Minoru Oshima
    Keiichi Okano
    Hironobu Suto
    Yasuhisa Ando
    Hideki Kamada
    Tsutomu Masaki
    Shigeo Takahashi
    Toru Shibata
    Yasuyuki Suzuki
    BMC Gastroenterology, 20
  • [34] MZB1 in borderline resectable pancreatic cancer resected after neoadjuvant chemoradiotherapy
    Miyake, Kentaro
    Mori, Ryutaro
    Homma, Yuki
    Matsuyama, Ryusei
    Okayama, Akiko
    Murakami, Takashi
    Hirano, Hisashi
    Endo, Itaru
    JOURNAL OF SURGICAL RESEARCH, 2017, 220 : 391 - 401
  • [35] Efficacy of neoadjuvant chemoradiotherapy followed by pancreatic resection for older patients with resectable and borderline resectable pancreatic ductal adenocarcinoma
    Suto, Hironobu
    Oshima, Minoru
    Ando, Yasuhisa
    Matsukawa, Hiroyuki
    Takahashi, Shigeo
    Shibata, Toru
    Kamada, Hideki
    Kobara, Hideki
    Masaki, Tsutomu
    Kumamoto, Kensuke
    Suzuki, Yasuyuki
    Okano, Keiichi
    HPB, 2023, 25 (01) : 136 - 145
  • [36] The Role of Neoadjuvant Chemoradiotherapy for Potentially Resectable Pancreatic Cancer
    Kim, Yoon Jae
    Choi, Jin-Young
    Chung, Yong Eun
    Kim, Hee Man
    Park, Semi
    Kim, Hong Jeoung
    Hong, Sung Pil
    Seong, Jinsil
    Park, Seung Woo
    Chung, Jae Bock
    Song, Si Young
    Bang, Seungmin
    GASTROENTEROLOGY, 2009, 136 (05) : A314 - A314
  • [37] Neoadjuvant Treatment in Locally Advanced and Borderline Resectable Pancreatic Cancer vs Primary Resectable Pancreatic Cancer
    Del Chiaro, Marco
    Valente, Roberto
    Arnelo, Urban
    JAMA SURGERY, 2017, 152 (11) : 1057 - 1057
  • [38] Neoadjuvant therapy versus upfront surgery for borderline-resectable pancreatic cancer
    Han, Sunjong
    Choi, Seong H.
    Choi, Dong W.
    Heo, Jin S.
    Han, In W.
    Park, Dae-Joon
    Ryu, Youngju
    MINERVA CHIRURGICA, 2020, 75 (01) : 15 - 24
  • [39] Neoadjuvant chemotherapy with FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy for borderline resectable and resectable pancreatic cancer (PREOPANC-2): A multicenter randomized controlled trial
    Koerkamp, B. Groot
    Janssen, Q. P.
    van Dam, J. L.
    Bonsing, B. A.
    Bos, H.
    Bosscha, K. P.
    Haberkorn, B. C. M.
    de Hingh, I. H. J. T.
    Karsten, T. M.
    Van der Kolk, M. B.
    Liem, M. S. L.
    Loosveld, O. J. L.
    Patijn, G. A.
    van Santvoort, H. C. M.
    de Vos-Geelen, J.
    van der Holt, B.
    Homs, M. Y. V.
    van Tienhoven, G.
    Besselink, M. G.
    Wilmink, H. W.
    ANNALS OF ONCOLOGY, 2023, 34 : S1323 - S1323
  • [40] Neoadjuvant chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer : Meta-analysis and trial sequential analysis of randomized controlled trials
    Hajibandeh, Shahab
    Hajibandeh, Shahin
    Intrator, Christina
    Hassan, Karim
    Sehmbhi, Mantej
    Shah, Jigar
    Mazumdar, Eshan
    Kausar, Ambareen
    Satyadas, Thomas
    ANNALS OF HEPATO-BILIARY-PANCREATIC SURGERY, 2023, 27 (01) : 28 - 39
12345